We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
NF-κB signaling, liver disease and hepatoprotective agents.
- Authors
Sun, B.; Karin, M.
- Abstract
The NF-κB signaling pathway has particular relevance to several liver diseases including hepatitis (liver infection by Helicobacter, viral hepatitis induced by HBV and HCV), liver fibrosis and cirrhosis and hepatocellular carcinoma. Furthermore, the NF-κB signaling pathway is a potential target for development of hepatoprotective agents. Several types of drugs including: selective estrogen receptor modulators (SERMs), antioxidants, proteasome inhibitors, IKK inhibitors and nucleic acid-based decoys have been shown to interfere with NF-κB activity at different levels and may be useful for the treatment of liver diseases. However, NF-κB also plays an important hepatoprotective function that needs to be taken into consideration during development of new therapeutic regimens.Oncogene (2008) 27, 6228–6244; doi:10.1038/onc.2008.300
- Subjects
HEPATITIS; HELICOBACTER diseases; HEPATIC manifestations of general diseases; APOPTOSIS prevention; LIVER disease treatment; SELECTIVE estrogen receptor modulators; THERAPEUTIC use of antioxidants; THERAPEUTICS
- Publication
Oncogene, 2008, Vol 27, Issue 48, p6228
- ISSN
0950-9232
- Publication type
Article
- DOI
10.1038/onc.2008.300